Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income	$ 33,999	$ 39,746
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	4,589	4,840
Provision for accounts and notes receivable	5,333	2,884
Share-based compensation and restricted stock	3,153	3,557
Deferred income taxes	(1,957)	(731)
Excess tax benefits from share-based payment arrangements	(849)	(156)
Change in fair value of contingent consideration	1,296	172
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	5,788	(48,352)
Inventories	4,797	(63,078)
Prepaid expenses and other assets	(1,741)	(4,630)
Other non-current assets	(2,973)	3,218
Accounts payable	(68,414)	38,300
Accrued expenses and other liabilities	5,616	4,373
Income taxes payable	1,375	(2,855)
Net cash provided by (used in) operating activities	(9,988)	(22,712)
Cash flows from investing activities:
Capital expenditures	(3,204)	(5,513)
Net cash provided by (used in) investing activities	(3,204)	(5,513)
Cash flows from financing activities:
Borrowings (repayments) on short-term borrowings, net	(3,912)	(2,214)
Borrowings (repayments) on revolving credit, net of debt issuance costs	21,342	68,965
Borrowings (repayments) on long-term debt	0	(25,000)
Contingent consideration payments	(4,716)	0
Exercise of stock options	1,458	3,367
Excess tax benefits from share-based payment arrangements	849	156
Net cash provided by (used in) financing activities	15,021	45,274
Effect of exchange rate changes on cash and cash equivalents	453	(3,203)
Increase (decrease) in cash and cash equivalents	2,282	13,846
Cash and cash equivalents at beginning of period	29,173	28,747
Cash and cash equivalents at end of period	$ 31,455	$ 42,593